Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
Alzheimer's disease and related dementias disproportionately affect minority racial and ethnic communities.
Why it matters
This study found that a dementia care workshop significantly increased community health workers' confidence in providing dementia care. It addresses improving care knowledge and preparedness, not treating, curing, or preventing the disease itself.
-
While both caregivers participated in physical activity, their case studies reveal opportunities to optimize physical activity interventions to support members of the caregiving dyad: (1) targeting mitochondrial fitness—the ability of mitochondria to maintain energy homeostasis with aging—so participants can mitigate the onset of NCDs, fatigue, and overall health outcomes; (2) promoting the self-care and psychological benefits of physical activity such as improved mood and social connectedness; and (3) improving the accurate perceptions of participants’ health and physical activity with specific measurable markers of physical activity.
Why it matters
These case studies describe opportunities to optimize physical activity interventions for dementia caregiving dyads, including targeting mitochondrial fitness and promoting self-care benefits. They are early case studies intended to inform future intervention development and do not test any treatment, cure, or prevention for Alzheimer's disease.
-
Dementia is a neurodegenerative disorder characterized by a significant decline in cognitive function.
Why it matters
This study found relationships between brainstem structural parameters and cognitive impairment in clinical dementia patients. However, it is an observational study and does not establish whether these structural changes cause dementia or can be used to treat or prevent it.
-
Respite for individuals caring for family living with dementia is a common way to take personal time away from caregiving.
Why it matters
This article reports that caregivers sacrificed leisure time and experienced diminished social connection, contributing to a decline in well-being. It suggests directing more attention and resources to meeting caregiver needs through leisure programming.
-
34/100
The latter often experience a loss of functional independence and geriatric syndromes including falls, undernutrition and neurocognitive disorders (1) requiring significant care that generates health expenditure.
Why it matters
This paper discusses hospital readmissions in frail older individuals and notes that the literature indicates it is easier to implement advance care planning when an older patient has a well-identified terminal-stage disease. It is a discussion of existing literature rather than a study testing a treatment, cure, or prevention.
-
We identified 11,480 beneficiaries in the IDEAS study sample and 3,008,067 in the eligible sample.
Why it matters
This study compared characteristics of racial and ethnic minority Medicare beneficiaries who participated in an amyloid imaging study versus those eligible, finding participants were more likely urban, healthier, and less likely dually enrolled in Medicare and Medicaid. It shows that research participants differ from the eligible population, which affects how broadly study results can be applied.
-
This study aimed to evaluate the effectiveness of the comprehensive dementia prevention application 'MELI' in enhancing cognitive function and alleviating depressive symptoms among older adults.A total of 50 participants aged 60 and older, enrolled in a dementia prevention program operated in Namdong-gu, Incheon, South Korea, were randomly assigned to either an experimental or a control group, with 25 participants in each.
Why it matters
This randomized study found that the MELI dementia prevention app improved cognitive function and reduced depressive symptoms in older adults over eight months. It suggests the app may support cognitive and emotional health, but it does not show that it treats, cures or prevents Alzheimer's disease.
-
Thirty-one articles were included. This conceptual analysis revealed the evolution of in-home respite care service content over time and summarized three key attributes.
Why it matters
This concept analysis of 31 articles describes in-home respite care as family-centered home care that provides temporary relief and is linked to reduced caregiving stress, improved quality of life, delayed institutional placement, and fewer safety risk events. It is a conceptual analysis, not a test of whether respite care causes these outcomes.
-
The early diagnosis of dementia, a progressive condition impairing memory, cognition, and functional ability in older adults, is essential for timely intervention and improved patient outcomes.
Why it matters
Using electronic health records from two hospitals in Thailand, this study found that adding clinically informed features and synthetic data improved machine learning models that distinguish dementia from conditions such as heart failure and aortic valve disorder. It is about detection methods, not treatment, cure or prevention.
-
34/100
This study examines the accuracy of CTseg segmentation software to diagnose Alzheimer's disease dementia and other dementias using routine CT scans from a New Zealand memory service.
Why it matters
This study found that CTseg segmentation software using routine CT scans had reasonable but limited accuracy for differentiating dementia from non-dementia, with sensitivity around 71-72% and specificity around 58-62%. It suggests some potential to aid diagnosis in real-world settings and does not address treatment or cure.
-
The first three elements concerned common awareness of collaborative ACP in dementia care, role clarification for various professions and actively working towards shared goals in collaborative ACP in dementia care.
Why it matters
This study developed a guidance document with six elements to help healthcare professionals work together on advance care planning in dementia care in nursing homes. It is about interprofessional collaboration in care planning, not treating, curing or preventing Alzheimer's disease.
-
Of the 1976 retrieved studies, 16 were included.
Why it matters
This scoping review found that adverse events such as falls, delirium and infections were more frequent among hospitalised people with dementia than those without. Only three studies explored links to outcomes, and the review could not establish a direct link, but suggests mitigating such events could help improve outcomes.
-
Multidomain lifestyle interventions can improve cognitive function and mobile health technologies can deliver cost-effective interventions.
Why it matters
This describes the development and usability testing of a smartphone app intended to support lifestyle interventions in people at high risk of dementia. It reports user satisfaction with usability, not whether the app prevents cognitive decline or dementia.
-
Research on AI's role in diagnosing neurological disorders is becoming widely recognized for its growing importance.
Why it matters
This scientometric analysis of 276 publications describes the growth of artificial intelligence research in diagnosing neurological disorders. It maps contributors and trends but reports no findings on treating, curing, or preventing Alzheimer's disease.
-
34/100
Digital health innovations hold diagnostic and therapeutic promise but may be subject to biases for underrepresented groups.
Why it matters
This focus-group study found that cultural differences in trust and acceptability of AI dementia diagnostics may be an unrecognized source of inequity. It concerns how people view diagnostic tools, not any treatment, cure, or prevention for Alzheimer's disease.
-
BackgroundDementia is one of the most prevalent conditions among older adults.
Why it matters
In a small randomized trial of 36 older people with dementia, action observation training improved some gait and cognitive measures compared to a control group. This is a small preliminary study and does not show a cure or prevention for Alzheimer's disease.
-
Food choices profoundly impact population health and the environment.
Why it matters
This study is about the accuracy of food choice self-reports in a simulated online grocery store, not about Alzheimer's disease, so it provides no information on treating, curing or preventing Alzheimer's. It found that reporting accuracy improved with memory aids, but this concerns shopping surveys only.
-
34/100
Recent discoveries indicating that the brain retains its ability to adapt and change throughout life have sparked interest in cognitive training (CT) as a possible means to postpone the development of dementia.
Why it matters
In this study, older adults with mild cognitive impairment who did ten days of selective attention training with an adaptive algorithm showed that initial performance, age, and pre-training cognitive scores were related to how much they improved. The study describes learning patterns during training rather than whether the training prevents dementia.
-
Sex was not a predictor of the total scores of MoCA.
Why it matters
This study provides normative data and cutoff scores for the Montreal Cognitive Assessment in older Peruvians, showing that a raw score above 18 indicates normal cognitive performance for the total sample. Age and education significantly influenced cognitive performance, with education being the strongest predictor, which supports the clinical use of the MoCA in Peru.
-
Mean activity from actigraphy did not differ within dyad members.
Why it matters
This study found that caregivers of people with dementia had shorter total sleep time and longer sleep onset latency than their partners, and that neuropsychiatric symptoms and caregiver burden were linked to worse caregiver sleep. It addresses caregiver wellbeing rather than treating, curing, or preventing Alzheimer's disease itself.
-
Alzheimer’s disease (AD) stands as a prevalent form of dementia, primarily impacting the elderly, and presently lacking any known cure.
Why it matters
This study used face mesh data from video recordings to classify dementia patients versus healthy subjects, and found that data augmentation improved deep learning performance. It is about detection and screening, not treating, curing or preventing Alzheimer's disease.
-
One of the most challenging tasks for neurologists is the early diagnosis of Alzheimer’s disease (AD).
Why it matters
This study developed a deep learning system using MRI features that achieved 91.6% accuracy for distinguishing cognitively normal individuals from those with MCI and 88.4% for multi-class diagnoses including predicting progression from normal to confirmed MCI. The work is a diagnostic tool development and does not test any treatment or prevention.
-
Exposure to fine particulate matter (PM ) pollution is associated with negative health outcomes including dementia, cardiovascular disease (CVD), and stroke due to increased levels of oxidative stress and inflammation among community-dwelling older adults.
Why it matters
This study set out to measure the association between fine particulate matter pollution and dementia, cardiovascular disease and stroke in older kidney transplant recipients. Only introductory background is provided in the available text, so no results on treating, curing or preventing Alzheimer's disease can be drawn.
-
Research participants enrolled in Falls Prevention EBPs reported decreased levels of loneliness and social isolation and were referred by physicians, social workers, and pharmacists using an order in the electronic medical record (EMR).
Why it matters
This study describes how a community exercise program for older adults was adopted by a health system and who was referred to it, including some people with cognitive changes. It reports on program reach and participant characteristics, not on any treatment, cure, or prevention of Alzheimer's disease.
-
Although White and non-White participants were both willing to test (∼77%), non-White participants were approximately four times more likely to test only if their results were not shared with their medical provider/insurer.
Why it matters
About 77% of both White and non-White participants were willing to test for dementia risk, but non-White participants were approximately four times more likely to test only if results were not shared with their medical provider or insurer. The study is about willingness to be screened, not about treating, curing, or preventing Alzheimer's disease.
From across this topic
10 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use
- A synthesis review of four literature reviews of disaster risk reduction education for children
- Impact of Hypertension on Cognitive Decline and Dementia
- Barriers and facilitators for GPs in dementia advance care planning: A systematic integrative review
- Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients
- Assistive Intelligence: A Framework for AI-Powered Technologies Across the Dementia Continuum
- Occlusion and brain function: mastication as a prevention of cognitive dysfunction
- Assessing the Effectiveness of eHealth Interventions to Manage Multiple Lifestyle Risk Behaviors Among Older Adults: Systematic Review and Meta-Analysis
- The Mini-Mental State Examination score and the clinical diagnosis of dementia
- Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial